BRCA1 and ovarian cancer: Finally, biopsy-derived organoids with introduced oncogenes and/or tumor suppressor mutations to induce cancer initiation fail to reveal critical molecular changes involved in BRCA1-related FTE transformation to ovarian cancer and cannot be used to improve early detection (Kopper et al., 2019; Lõhmussaar et al., 2020).